Immediate Impact

4 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
2 intermediate papers

Works of Fabio Sangalli being referenced

Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
1999

Author Peers

Author Last Decade Papers Cites
Fabio Sangalli 798 544 459 38 1.7k
Darren A. Yuen 507 744 377 71 2.1k
Yufeng Huang 474 661 595 56 1.9k
Marie Jeansson 901 798 214 28 2.0k
Samuel S. Blumenthal 954 402 283 39 1.9k
Tracy McGowan 1041 817 267 42 2.2k
Maarten B. Rookmaaker 292 1106 290 64 2.1k
Barbara M. Klinkhammer 542 498 132 52 1.9k
Shigehiro Doi 865 681 122 71 2.1k
Dong Cheol Han 933 804 228 51 2.0k
Sumant S. Chugh 1240 760 321 40 2.1k

All Works

Loading papers...

Rankless by CCL
2026